Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-05-16

FDA Approved: ESTRING — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

The FDA granted a supplemental approval for ESTRING (estradiol) from Pfizer, updating the product's labeling/indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ESTRING (Estradiol)

Snippet

SUPPL AP for ESTRING (ESTRADIOL)